Ashok Meshram
YOU?
Author Swipe
View article: Ameloblastoma Revisited: Classification updates, treatment modalities, and outcomes
Ameloblastoma Revisited: Classification updates, treatment modalities, and outcomes Open
View article: Ventilator Associated Pneumoniaina Medical Intensive Care Unit: Incidence, Risk factors and Mortality
Ventilator Associated Pneumoniaina Medical Intensive Care Unit: Incidence, Risk factors and Mortality Open
BACKGROUND: Ventilator Associated Pneumonia (VAP) increases hospital costs, lengthens the hospital length of stay, and significantly contributes to patients discomfort, morbidity, and mortality. The aim was to look at the patient character…
View article: Oral and maxillofacial myiasis: A case series
Oral and maxillofacial myiasis: A case series Open
View article: To Study Level of Gonadal Hormone in Cancer Patients Receiving Chemotherapy
To Study Level of Gonadal Hormone in Cancer Patients Receiving Chemotherapy Open
Objectives: The objective of this study was to study the alteration in levels of testosterone, luteinising hormone (LH), follicle-stimulating hormone (FSH) and prolactin in male cancer patients’ post-chemotherapy who have been started on d…
View article: Successful Renal Transplant in End-Stage Renal Disease with Chronic Immune Thrombocytopenia using Thrombopoietin Receptor Agonists and Intravenous Immunoglobulin
Successful Renal Transplant in End-Stage Renal Disease with Chronic Immune Thrombocytopenia using Thrombopoietin Receptor Agonists and Intravenous Immunoglobulin Open
Chronic kidney disease in immune thrombocytopenia (ITP) is uncommon, and renal transplant in this setting is rare. We discuss the successful renal transplant of a 29-year-old male with chronic ITP. During transplant, he was managed with th…
View article: Safety and efficacy of azathioprine in immune thrombocytopenia.
Safety and efficacy of azathioprine in immune thrombocytopenia. Open
We conclude that azathioprine has a good response rate in chronic ITP patients. It is well-tolerated with minimal and manageable side effects.
View article: The clinical profile, management, and outcome of febrile neutropenia in acute myeloid leukemia from resource constraint settings
The clinical profile, management, and outcome of febrile neutropenia in acute myeloid leukemia from resource constraint settings Open
Introduction: Acute myeloid leukemia (AML) is the commonest leukemia in adults. Mortality in thew first 30-days ranges from 6% to 43%, while infections account for 30–66% of early deaths. We aim to present our experience of infections in n…
View article: Assessment of bleeding risk by sonoclot in acute lymphoblastic leukemia
Assessment of bleeding risk by sonoclot in acute lymphoblastic leukemia Open
Background: At the same level of thrombocytopenia, patients with acute lymphoblastic leukemia (ALL), receive more prophylactic platelet transfusion in comparison to immune thrombocytopenia (ITP). Routine investigation cann't differentiate …
View article: Impact of bisphosphonate and anti-myeloma therapy on bone turnover markers in multiple myeloma
Impact of bisphosphonate and anti-myeloma therapy on bone turnover markers in multiple myeloma Open
Background: Bone involvement is a defining feature of symptomatic multiple myeloma (MM). There is little information on changes in bone mineral metabolism that occur with bisphosphonates and anti-myeloma medication. Methods: Newly-diagnose…